Y Gao1, H J Shen2, P Zhou2, H Hu2, J L Tang2, L L Peng2, J Tong2. 1. Department of Endocrinology, The Second People's Hospital of Lianyungang, Lianyungang 222000 China. yunminggao@126.com. 2. Department of Endocrinology, The Second People's Hospital of Lianyungang, Lianyungang 222000, China.
Abstract
OBJECTIVE: Changes in soluble intercellular adhesion molecule-1 (sICAM-1) and E-selectin levels as well as leukocyte count were examined in this study to explore the relationship between leukopenia and ICAMs in Graves' disease (GD). METHODS: Fasting blood samples were obtained from 37 GD patients with normal leukocytes and 32 GD patients with leukopenia. Enzyme-linked immunosorbent assay (ELISA) was performed to determine serum sICAM-1 and E-selectin levels for comparison. The same analyses were repeated for the GD patients with leukopenia after glucocorticoid treatment (15 mg/day to 30 mg/day prednisone). RESULTS: The ELISA results showed that E-selectin levels were higher in GD patients with leukopenia than those with normal leukocytes (p < 0.05), but these levels decreased after glucocorticoid (prednisone) treatment (p < 0.05). No significant change in sICAM-1 levels was observed (p = 0.12). Correlation analysis showed that leukocyte count and E-selectin were negatively correlated (r = -0.778; p < 0.05). CONCLUSION: E-selectin may have an important function in GD with leukopenia, and glucocorticoids (prednisone) could decrease E-selectin level, which may be a new therapy target for GD with leukopenia.
OBJECTIVE: Changes in soluble intercellular adhesion molecule-1 (sICAM-1) and E-selectin levels as well as leukocyte count were examined in this study to explore the relationship between leukopenia and ICAMs in Graves' disease (GD). METHODS: Fasting blood samples were obtained from 37 GDpatients with normal leukocytes and 32 GDpatients with leukopenia. Enzyme-linked immunosorbent assay (ELISA) was performed to determine serum sICAM-1 and E-selectin levels for comparison. The same analyses were repeated for the GDpatients with leukopenia after glucocorticoid treatment (15 mg/day to 30 mg/day prednisone). RESULTS: The ELISA results showed that E-selectin levels were higher in GDpatients with leukopenia than those with normal leukocytes (p < 0.05), but these levels decreased after glucocorticoid (prednisone) treatment (p < 0.05). No significant change in sICAM-1 levels was observed (p = 0.12). Correlation analysis showed that leukocyte count and E-selectin were negatively correlated (r = -0.778; p < 0.05). CONCLUSION:E-selectin may have an important function in GD with leukopenia, and glucocorticoids (prednisone) could decrease E-selectin level, which may be a new therapy target for GD with leukopenia.
Authors: T Arao; I Morimoto; A Kakinuma; O Ishida; K Zeki; Y Tanaka; N Ishikawa; K Ito; K Ito; S Eto Journal: J Clin Endocrinol Metab Date: 2000-01 Impact factor: 5.958
Authors: Anika Stadtmann; Laura Brinkhaus; Helena Mueller; Jan Rossaint; Matteo Bolomini-Vittori; Wolfgang Bergmeier; Hugo Van Aken; Denisa D Wagner; Carlo Laudanna; Klaus Ley; Alexander Zarbock Journal: Eur J Immunol Date: 2011-06-07 Impact factor: 5.532
Authors: David Frommhold; Anna Kamphues; Ingrid Hepper; Monika Pruenster; Ivan K Lukic; Ines Socher; Victoria Zablotskaya; Kirsten Buschmann; Baerbel Lange-Sperandio; Jürgen Schymeinsky; Eduard Ryschich; Johannes Poeschl; Christian Kupatt; Peter P Nawroth; Markus Moser; Barbara Walzog; Angelika Bierhaus; Markus Sperandio Journal: Blood Date: 2010-04-20 Impact factor: 22.113
Authors: Mahdi Bijanzadeh; Nallur B Ramachandra; P A Mahesh; Mysore R Savitha; G S Vijayakumar; Pradeep Kumar; B S Manjunath; B S Jayaraj Journal: Lung Date: 2009-08-23 Impact factor: 2.584
Authors: Lorenzo Scappaticcio; Giuseppe Bellastella; Maria Ida Maiorino; Miriam Longo; Claudia Catalano; Katherine Esposito; Giuseppe Paolisso; Maria Rosaria Rizzo Journal: Hormones (Athens) Date: 2020-07-08 Impact factor: 2.885